Tara Kieffer
Fortuna: 446 453 $ al 31/05/2026
Fortuna: 446 453 $ al 31/05/2026
Tara L.
Kieffer is Chief Product Strategy Officer at Enanta Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Kieffer was VP-External Innovation & Business Development at Vertex Pharmaceuticals, Inc. from 2018 to 2020.
Education includes undergraduate studies at Colgate University and a doctorate from The Johns Hopkins University School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/02/2026 | 33.925 ( 0,12 % ) | 446 453 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 08/12/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/10/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Colgate University
Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.